Delivery Order SPE2DR25D2212-SPE2DR26FB9GM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,633.32 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The sensors will be delivered to AmerisourceBergen's headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,368.94 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on October 17, 2025, with completion expected by October 20, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The sensors will be supplied from the...
- The Defense Logistics Agency awarded a delivery order valued at $11,598.25 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on September 26, 2025, with a completion date of September 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award for continuous glucose monitoring supplies to support military and federal healthcare operations. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order valued at $8,130.53 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 4, 2025, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical and medical device supply portfolio. The contract specifies performance at the vendor's Conshohocken, Pennsylvania location, which serves as...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $19,652.04 for Freestyle Libre 3 Plus Sensors, with completion targeted for September 25, 2025. This non-competitive delivery order was issued on September 24, 2025, and will be performed at the company's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device distributor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,584.76 for Freestyle Libre 3 Plus Sensors on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,070.04 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is being performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,720.12 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors, with a completion date of June 9, 2025. This non-compete, firm fixed-price delivery order was issued on June 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device distributor supporting federal healthcare...
- The Defense Logistics Agency has awarded a delivery order valued at $8,707.71 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors. This is a competitively awarded, firm fixed price delivery order with an ultimate completion date of September 22, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical and medical device supplier to the federal government. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $21,065.30 delivery order to AmerisourceBergen Drug Corp for FreeStyle Libre 3 Plus sensors, with an ultimate completion date of September 30, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and is classified as a child order under AmerisourceBergen's larger pharmaceutical supply vehicles with DLA. The sensors will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2212Indefinite Delivery Contract
- SPE2DR25D2212-SPE2DR26FB9GMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,235.95 to AmerisourceBergen Drug Corp for Freestyle Libre 3 Plus Sensors on November 18, 2025, with a completion date of November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive role as a federal medical supplier, particularly for defense and military healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medical products and pharmaceuticals to support military healthcare programs worldwide. Freestyle Libre 3 Plus Sensors are continuous glucose monitoring devices used for diabetes management, consistent with AmerisourceBergen's portfolio of specialized medical supplies and diabetes-related medications distributed through federal contracts across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.2k | 11/18/25 |